Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Leap Wireless International Inc. ( LEAP - Analyst Report ) posted disappointing financial results for the second quarter of 2012, missing the Zacks Consensus Estimates. The results were significantly hurt by higher customer churn rate. Leap Wireless has restructured its business model through which it is emphasizing on higher ARPU generating smartphone subscribers, while shedding less profitable wireless broadband subscribers as these users generally place huge load on its network.
We believe the decision of management to offer iPhone of Apple Inc. ( AAPL - Analyst Report ) is a 50-50 winning opportunity for the company as it has to pay huge contract money to Apple. Sequential fall in ARPU was a major concern since the company has to opt for promotional activities to contain subscriber churn. Meanwhile, the stock price plummeted nearly 47% in the last year providing a cushion for further downslide. We believe Leap Wireless is currently fairly valued and thus reaffirm our long-term Neutral recommendation.
On August 28, Leap Wireless disposed 23 PCS and 13 AWS spectrum to Verizon Communications Inc. ( VZ - Analyst Report ) for about $120 million. Additionally, the company also acquired 12 MHz of 700 MHz A block spectrum in Chicago from Verizon. In last April, Leap Wireless entered into a spectrum sharing partnership with T-Mobile USA. The new partnership will expand the two carrier’s 4G LTE network capability.
Leap Wireless will get expanded broadband spectrum in Phoenix and Texas and T-Mobile will get additional spectrum in Alabama, Illinois, Missouri, Minnesota, and Wisconsin. Leap Wireless will offer LTE services in two-thirds of its overall network foothold in the next 2-3 years.
Read the full reports :
Analyst Report on AAPL
Analyst Report on VZ
Analyst Report on LEAP